Aseptic process simulation runs enabling clinical manufacture of Primaverah for Phase 1/2A clinical use

Read full text
Authors: Therapeutic Innovation Australia
Cited by: 0

Fields of Study & Subjects

Viral Infectious Diseases and Gene Expression in Insects Protein purification and stability Pharmaceutical studies and practices

Publication details

Journal / source
Therapeutic Innovation Australia
Publication date
17 February 2026
Language
EN